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DISCUSSION
Dr. Alberto Ortiz (Medico Adjunto, Division of Ne-
phrology, Fundacio´n Jime´nez Dı´az, Universidad Auto´-
noma de Madrid, Madrid, Spain): This patient illustrates
an increasingly appreciated finding in renal biopsies: the
presence of apoptotic cells. Several clinical features
could have contributed to tubular cell apoptosis in this
patient. They include diabetes, proteinuria, and HIV
infection [1–4]. In this Forum, I will discuss the molecular
regulation (both intracellular and extracellular) of apo-
ptotic cell death, the role of apoptosis in renal injury,
and its role in specific renal diseases. I will conclude with
suggestions for future research both at the cellular andCASE PRESENTATION
clinical levels. The topic of apoptosis is fascinating,A 35-year-old woman presented to the emergency room at
timely, and exceedingly complex. I shall begin by dis-Fundacio´n Jime´nez Dı´az in Madrid because of edema. She had
a 10-year history of insulin-dependent diabetes mellitus. She cussing the molecular regulation of apoptotic cell death,
had used illicit intravenous drugs in the past and was HIV focusing on renal disease when data are available.
positive. Her blood pressure was 180/110 mm Hg. The rest of Tissue cell number is carefully regulated through the
the physical findings were unremarkable. Blood chemistries
balance between cell birth (mitosis) and cell death, withincluded creatinine, 5.4 mg/dL; BUN, 88 mg/dL; serum albu-
occasional participation of cell migration or cell transdif-min, 2.3 g/dL; and cholesterol, 140 mg/dL. The white blood
cell count was 6220/mm3; hemoglobin, 9.6 g/dL; platelets, ferentiation. Cell birth and cell death are intertwined,
76,000/mm3; CD41 lymphocytes, 190/mm3; and HbA1c, 8.4%. and their rates typically increase or decrease in tandem.
Anti-HCV antibody was positive; HbsAg was negative; C3, 76 This coordination suggests that common mechanisms
mg/dL; C4, 40 mg/dL. Serum immunoglobulins were within
regulate cell birth and cell death, only some of whichthe normal range. Cryoglobulins were negative. The urine con-
have been identified. An imbalance between these pro-tained 6 g protein/24 hours. Urinary sediment disclosed hema-
turia with marked morphologic changes in erythrocytes. The cesses can result in disorders of cell number character-
patient’s renal function had been normal six months prior to ized by an excessive cell number (for example, neoplasia,
admission but had progressively deteriorated. A renal biopsy proliferative glomerulonephritis) or insufficient cell num-
showed mesangial proliferative glomerulonephritis and tubular
ber (for example, neurodegenerative disease, renal at-injury. The tubular brush border was lost and the lumen was
rophy).dilated with frequent sloughing of apoptotic tubular cells into
Two modes of cell death have been differentiated:the lumen (Fig. 1). Red blood cell casts were visible in some
tubular lumens. The patient refused medical treatment. Six apoptosis and necrosis. Apoptosis was defined morpho-
months after the biopsy, her renal function continued to deteri- logically in 1972, but until the late 1980s its functional
orate.
and therapeutic implications were not fully evident [5].
For this reason the term necrosis in the older literature
does not indicate a specific form of cell death.The Nephrology Forum is funded in part by grants from Amgen,
Incorporated; Merck & Co., Incorporated; AstraZeneca LP; Dialysis Apoptotic cell death (“cell suicide”) is an active pro-
Clinic, Incorporated; and R & D Laboratories. cess under molecular control [6–13]. Indeed, the fact
that apoptosis requires energy for cell death to proceedKey words: cytokines, tumor necrosis factor, clusterin, caspase, Bcl-2,
FasL. demonstrates that it is an active process. However, the
distinction between the two modes of cell death is notÓ 2000 by the International Society of Nephrology
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Fig. 1. Apoptotic cells within tubular wall (arrows) (H&E stain, original magnification 3200). Courtesy of Antonio Barat, M.D., Fundacio´n
Jime´nez Dı´az, Madrid, Spain.
always clear-cut. From a therapeutic point of view, we
are interested in any form of cell death that can be
manipulated by various maneuvers, and we are focusing
today on factors designed to interfere with apoptosis.
Teleologically, necrosis is accidental cell death, while
apoptosis is an active dismantling of cellular structures,
organized in such a way to limit damage to surrounding
tissue. Apoptosis, an essential process, removes un-
wanted and harmful cells and maintains homeostasis of Fig. 2. Pyknotic nuclei are small condensed nuclei from apoptotic cells.
Note pyknotic nuclei and shrunken cytoplasm in murine tubular epithe-cell number. Most tissues, especially the skin, gut, and
lial cells exposed to 300 mg/mL acetaminophen for 24 hours (arrow)
immune system, depend on well-ordered apoptosis and (H&E stain, original magnification 3400).
cell replacement for normal functioning. Approximately
100,000 cells are produced every second in a human,
and a similar number die through apoptosis [7]. For
the in situ detection of fragmented DNA in individualthis reason, any therapeutic measure that interferes with
cells in tissue sections. However, this technique requiresapoptosis should be targeted as narrowly as possible to
great expertise, as false-positive and false-negative re-a single cell population.
sults are common, and simultaneous identification of theApoptosis is characterized by morphologic and func-
typical morphologic features is recommended. Althoughtional changes. Apoptotic cells detach from the culture
cell membrane integrity is preserved until advancedsubstrata or basal membranes and undergo cellular and
stages of the process, the composition of the cell mem-nuclear shrinkage, nuclear condensation, membrane
brane changes, allowing the rapid recognition and en-blebbing, and cell and nuclear fragmentation (Fig. 2).
gulfment of apoptotic cells by healthy adjacent cells,DNAses fragment DNA into internucleosomal-sized
before they lose cell membrane integrity and leak in-fragments that yield a typical ladder pattern when sepa-
flammatory molecules. As a result, the half-life of therated by gel electrophoresis. Terminal deoxynucleotidyl
transferase-mediated nick end labeling (TUNEL) allows apoptotic morphology is short (one to two hours) and
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apoptosis does not generate florid inflammation. Both factors for tubular epithelium and renal fibroblasts are
summarized in Table 1 [18–22].factors make apoptosis inconspicuous. Even in tissues
Clusterin (SPG40) was one of the earliest proteinssuffering a significant cell loss through apoptosis, the
associated with the occurrence of apoptosis, althoughnumber of visible apoptotic cells remains low.
for years its role in the process was unknown. It is nowThe classic example of necrosis is ischemic cell death,
evident that clusterin is a multifunctional protein thatcharacterized by an increase in cell volume and an early
protects cells from apoptosis in vitro and in vivo [23, 24].loss of cell membrane integrity. The term “oncosis” has
In mesangial cells, clusterin is down-regulated by lethalbeen proposed for this form of cell death but is not widely
stimuli such as serum deprivation and tumor necrosisemployed. In this nomenclature, necrosis would denote
factor (TNF) (abstract, Ortiz A, et al, J Am Soc Nephrolthe final stage of cell death that has proceeded either
4:626, 1993). Exogenous clusterin prevents H2O2 cytotox-through oncosis or apoptosis (secondary necrosis) [5]. I
icity in tubular cells [24].believe this terminology is confusing, and I will use only
Two kinds of lethal factors induce apoptosis: thosethe terms apoptosis and necrosis. Nevertheless, differences
that activate specific cell death receptors and those thatbetween apoptosis and necrosis are not absolute, and
damage the cell in the absence of receptor activation.even the term “necrapoptosis” has been coined. Cells
Experimental evidence supports a role for TNF/TNFRsuffering potentially lethal metabolic changes often try to
(TNF receptor) and Fas ligand (FasL)/Fas in renal injury.“commit suicide” by activating apoptotic pathways before
There is less information on other cytokine/receptor sys-they are killed. However, inactivating these apoptotic
tems, although some are expressed by renal cells. Thepathways might not save the cell from death [7]. The
simultaneous description of the same cytokine or recep-intensity of the lethal stimulus, the availability of energy
tor by independent groups justifies the existence of sev-as ATP, or the inactivation of caspases can determine
eral names for the same molecule. Lethal cytokines be-whether the cell dies through apoptosis or necrosis
longing to the TNF superfamily bind to and activate[14, 15]. Moreover, apoptotic cells that are not engulfed
cell membrane death receptors (Table 2) [9]. A fineby adjacent cells undergo secondary necrosis, defined as
regulation of the system protects innocent bystandersa loss of cell membrane integrity. Finally, survival pro-
from accidental death, and includes the existence of solu-teins such as Bcl-2 and BclxL protect against cell death
ble receptors and decoy receptors that behave like cyto-from either apoptosis or necrosis [10].
kine antagonists (Table 2, Fig. 3) [9]. Moreover, someCorresponding to its importance in cell number ho-
lethal cytokines, such as TNF and FasL, are releasedmeostasis, apoptosis is a tightly regulated phenomenon.
from the cell membrane by the action of enzymes. TheBoth extracellular and intracellular molecules provide
lethality of soluble FasL is up to 1000 times less than
multiple regulatory and counter-regulatory pathways. I
that of membrane-bound FasL, and soluble FasL even
will review the current understanding of apoptotic regu- can antagonize that lethal effect of membrane-bound
lation, making reference to renal cells when such data FasL [9, 25].
are available. Both TNF and FasL have been extensively investi-
gated in renal cells. In the kidney, both cytokines canExtracellular regulation of apoptosis
be synthesized by infiltrating leukocytes and intrinsic
Apoptotic cell death is usually a response to the cell renal cells [25, 26]. The main source of intrinsic FasL is
microenvironment, where the absence of certain survival the tubular epithelial cell [27]. Both TNF and FasL can
factors or the presence of lethal factors promotes apopto- induce apoptosis of mesangial cells, tubular epithelial
sis. Surrounding cells, soluble mediators, and the extra- cells, renal endothelial cells, and renal fibroblasts
cellular matrix regulate cell death and survival. Sur- [28–32]. The sensitivity of these cell types to cell death
rounding cells can synthesize survival or lethal factors varies with the cell microenvironment, however. Under
or compete for binding to such factors. Most cells need basal conditions, tubular cells are quite resistant to FasL-
survival signals from their surroundings to remain alive, induced apoptosis [31–33], as expected by their constitu-
and these survival factors vary depending on cell type tive expression of the cytokine. But they become sensi-
and functional status. Survival factors for human and rat tized to the lethal effects of FasL upon exposure to in-
mesangial cells include IGF-I, IGF-II, and bFGF; EGF, flammatory cytokines [27, 31, 34]. By contrast, Fas
PDGF, and TGF-b1 have no effect [16]. Collagen IV and activation induces death in nonstimulated mesangial
laminin, components of normal mesangial extracellular cells in vitro and in vivo [30, 32], and the sensitivity to
matrix (ECM), protect rat mesangial cells from apoptosis Fas-induced death is increased by inflammatory cyto-
induced by serum starvation and DNA damage by a b1- kines [30, 31]. Although Thy-1 is not considered a “death
integrin-mediated mechanism [17]. By contrast, patho- receptor,” anti-Thy-1 antibodies induce apoptosis of
logic components of the glomerular ECM, such as colla- mesangial cells that appears to result from activation of
this receptor [35].gen I and fibronectin, offer no protection [17]. Survival
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Table 1. Partial list of lethal and survival factors for renal cells
Category Lethal factors Survival factors
Cytokines TNF (MC, TEC, RF, RE) EGF, proHB-EGF, HGF (TEC)





and other proteins Integrin-mediated (TEC)
Clusterin (TEC)
Collagen IV, laminin (MC)
Lipids Thromboxane A2 Lysophosphatidic acid
Small molecules Oxygen radicals, H2O2 (MC, TEC)
NO (MC, TEC, RE)
Drugs Cyclosporine A, cisplatin, acetaminophen,
aminoglycosides (TEC),
HMG-CoA inhibitors (MC)
Other Verotoxin, HIV (TEC)
Pressure (MC)
Abbreviations are: MC, mesangial cells; TEC, tubular epithelial cells; RF, renal fibroblasts; RE, renal endothelium; TNF, tumor necrosis factor; NO, nitric oxide;
HMG-COA, 3-hydroxy-3-methylglutaryl coenzyme A; HIV, human immunodeficiency virus; EGF, epithelial growth factor; HGF, hepatocyte growth factor; IGF,
insulin-like growth factor; bFGF, basic fibroblast growth factor; PDGF, platelet-derived growth factor. Not all cell death modulatory factors have been tested in
every renal cell type.
Table 2. Partial list of lethal cytokines and corresponding rine tubular epithelial cells and renal fibroblasts from
death receptors
TNF- and Fas-induced apoptosis [22, 42]. Serum also
Soluble (s) or decoy protected tubular cells against apoptosis induced by
Cytokine Receptor receptors nephrotoxins (abstract, Lorz C, et al, J Am Soc Nephrol
TNF TNFR1 sTNFR 9:596A–597A, 1998). Serum frequently is used as a
FasL/Apo-1L/
source of survival factors in cell culture experiments.CD95L Fas/Apo-1/CD95 DcR3
sFas Other lethal stimuli, such as lovastatin, induce apoptosis
TRAIL/Apo-2L DR4/TRAILR1 DcR1/TRAILR3 only in actively proliferating mesangial cells and spare
DR5/TRAILR2/
quiescent cells grown in serum-free conditions [41]. InApo-2/Killer/TRICK2 DcR2/TRAILR4
Apo-3L/TWEAK DR3/TRAMP/WSL-1/AIR/ theory, this property could be used therapeutically to
LARD ? target proliferating mesangial cells in vivo.
? DR6 ?
LT-1 ? ?
Intracellular regulation of apoptosis
The intracellular regulation of apoptosis is at the fore-
front of biomedical research. A complete review is be-
yond my scope here, so I will briefly summarize currentLethal factors that cause receptor-independent cell
knowledge in the field. Although different pieces of thestress usually kill by a mechanism involving mitochon-
puzzle have emerged, the exact relationship betweendria. Cellular stress can induce the expression of death
them is open to interpretation, and schemes and path-ligands and receptors. However, their inhibition or an-
ways described in this review are necessarily oversimpli-tagonism doesn’t always rescue the cell from death. Ta-
fied and subject to modification.ble 1 summarizes lethal stimuli for renal cells [3, 14, 15,
The intracellular regulation of apoptosis is highly con-36–41].
served in the phylogenetic scale, and relevant mamma-As is evident from what I have said so far, the cellular
lian proteins function in invertebrates and vice-versa.microenvironment contains multiple survival and lethal
Seminal studies in the nematode C. elegans defined afactors. The interaction between survival and lethal fac-
basic role for CED-3, CED-4, CED-9, and EGL-1 pro-tors varies in a stimulus- and cell-specific manner. The
teins in apoptosis [7]. Both CED-3 and CED-4 are re-absence of survival factors can predispose renal cells to
quired for cell death to proceed; CED-4 associates withdeath induced by lethal cytokines and nephrotoxic drugs.
CED-3 and promotes the proteolytic activation ofThe survival factors IGF-I and IGF-II, but not bFGF,
CED-3. CED-3 activation is inhibited by CED-9; EGL-1protected mesangial cells against DNA-damaging agent-
binds to and inhibits CED-9 by disrupting the associationand protein synthesis inhibitor-induced apoptosis [16].
between CED-4 and CED-9, thus promoting CED-3 ac-However, neither of them prevented Fas-induced apo-
tivation [7].ptosis [16]. By contrast, the survival factors present in
serum, or single cytokines such as IGF-I protected mu- CED-3 is homologous to the mammalian caspases.
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Fig. 3. Extracellular regulation of lethal cyto-
kine-induced cell death: the case of Fas ligand
(FasL). Abbreviations are: DcR3, decoy re-
ceptor-3; sFas, soluble Fas; sFasL, soluble
FasL.
Table 3. Partial list of mammalian caspases
Group Sequence specificity Function Caspase (other names)a
I WEHD Inflammation 1 (Interleukin-1b-convertase: ICE)
Inflammation? 4 (ICE-rel II, TX, ICH-2)
Inflammation? 5 (ICE-rel III, TY)
II DEHD Effector of apoptosis 2 (ICH-1)
Effector of apoptosis 3 (CPP32, apopain, yama)
Effector of apoptosis 7 (Mch3, ICE-LAP3, CMH-1)
III (LV) EXD Effector of apoptosis 6 (Mch2)
Initiation/signaling of apoptosis 8 (FLICE/MACH/Mch5)
Initiation/signaling of apoptosis 9 (ICE-LAP6, Mch6)





a Caspases 1 through 10 can have additional names because they were independently described by several groups before a consensus developed for the caspase
nomenclature.
Caspases are intracellular cysteine proteases that cleave main-containing protein most homologous to apoptotic
members of the Bcl-2 family (Table 4) [7]. The main ortheir substrates following an aspartate residue (Table
3) [12]. Some caspases are largely responsible for the only known function of these protein families is regula-
tion of cell death, but some of the signal transductionproteolytic processing of inflammatory cytokines; others
are directly involved in the process of apoptosis. Cas- pathways that participate in cell death have important
roles in other cellular processes, and it is difficult topase-1 was the first caspase described, but its role in
apoptosis later was shown to be marginal. Its main known classify them solely as cell death factors.
The cell death process is activated by intracellularfunction is processing of IL-1b. CED-4 is homologous
to Apaf-1 and FLASH, nucleotide-binding, oligomeriza- factors in response to a lethal cell microenvironment.
Known intracellular activators of apoptosis include so-tion domain-containing-proteins [43]. They function as
“chaperones” to increase the local concentration of pro- called “death receptors,” apoptotic members of the Bcl-2
family, and mitochondrial injury (Fig. 4). Death recep-caspases and facilitate their autocatalytic activation.
CED-9 has significant homology to the mammalian Bcl-2 tors belong to the TNF receptor superfamily, which is
characterized by homology in the extracellular domains.family of survival proteins (Table 4); this family also
includes apoptotic members [10]. EGL-1 is a BH3 do- In addition, death receptors contain a cytoplasmic death
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Table 4. Partial list of Bcl2 family proteins and other protein that binds to the CD27 cytoplasmic tail, Siva,
their role in apoptosis
has a DD homology region and promotes apoptosis [45].
Survival proteins Apoptotic proteins Some members of the Bcl-2 family can trigger apopto-
Bcl-2a Bax sis (Table 4). For example, Bax overexpression induces
BclxLa,b Bak caspase-independent cell death, and Bax is required for
Bclw Bok/Mtd
certain modes of cell death, such as survival factor depri-Al BclxSb
Mcll BH3-domain-only proteins vation in neurons [10]. Mechanisms for their apoptotic
Bid, Bad, Bik/Nbk/Blk, Bim/Bod, Hrk/DP5 activity include (1) binding and inhibition of Bcl-2 or
a Caspase-generated Bcl-2 and BclxL fragments may promote cell death BclxL, thus triggering the release of caspases, and (2)
b BclxL and BclxS are isoforms derived from alternative splicing of the same
inducing the opening of mitochondrial membrane chan-gene
nels, thus promoting the release of mitochondrial apo-
ptotic factors into the cytoplasm. Bax shuttles from its
cytoplasmic location to the mitochondria upon induction
domain (DD). Binding to the lethal cytokine promotes of apoptosis by glucose-free hypoxia in tubular cells;
death receptor oligomerization and recruitment of sev- other apoptotic stimuli, such as serum deprivation or
eral adaptor proteins and procaspases to a receptor com- nitric oxide (NO), increase Bax expression in tubular
plex (DISC, death-inducing signaling complex). The Fas and mesangial cells, respectively [39, 40, 42]. Both TNF
receptor DISC includes FADD, an adaptor protein that and LPS increase Bak and induce apoptosis in glomeru-
contains a DD that allows interaction with the DD in lar endothelial cells [28]. A subfamily containing only
death receptors, and a death effector domain (DED) the BH3 domain (BH3-only proteins) was recently char-
that allows it to interact with DED domain-containing acterized (Table 4). Bad can bind to and inhibit BclxL,
procaspase-8 [9]. The CED-4-like protein, FLASH, also and its ability to do so is down-regulated by phosphoryla-
is recruited to the activated Fas receptor and interacts tion after survival receptor engagement by cytokines [7].
with procaspase-8 via a DED domain [43]. Procaspase-8 Bid is the molecular connection between receptor-
is cleaved and activated in the course of Fas engagement. induced apoptosis and the mitochondria [8].
Ligand-independent activation of cell death signaling by Mitochondria are key participants in apoptosis that is
death receptors has been described in a variety of situa- not triggered by death receptors and also can contribute
tions [44], although not yet in renal cells. Mechanisms to cell death after death receptor activation [13]. Mito-
exist to limit the spontaneous signaling from DD-con- chondrial changes during apoptosis include (1) dissipa-
taining receptors, such as the inhibitory protein silencer tion of the mitochondrial transmembrane potential gra-
of DD (SODD) and FLIP, which inhibits caspase-8 acti- dient (DCm) due to the opening of a large conductance
vation by binding to FADD [9]. channel known as the permeability transition (PT) pore,
Type I and type II cells are differentiated according and (2) release of proteins, such as cytochrome c and
to their efficiency in forming a death-signaling complex AIF, from the mitochondrial intermembrane space to
upon FasL binding to Fas [9]. Type II cells have low the cytosol, where they participate in the effector phase
efficiency in forming this complex, and the lethal signal of apoptosis by directly activating caspases [13]. Dissipa-
must be amplified through recruitment of the mitochon- tion of the mitochondrial transmembrane potential gra-
drial pathway for apoptosis. The amount of cell surface dient and the release of apoptotic factors can occur inde-
Fas is one of the determinants of cell sensitivity to Fas- pendently of each other. In this regard, mitochondrial
induced death. Mesangial cells, tubular cells, and renal injury can cause caspase-independent cell death that
fibroblasts express cell surface Fas receptors, but there might not have the apoptotic morphology [13]. The na-
are few data regarding their expression of soluble Fas ture of the permeability transition pore is currently under
and decoy receptors [25]. A number of apoptotic factors intense investigation. Evidence exists for the participa-
or settings involved in the pathogenesis of renal injury tion of VDAC (porin or voltage-dependent anion chan-
up-regulate Fas expression in renal cells, and at least nel) and ANT (adenine nucleotide translocator) [8].
some of them render the cells more susceptible to FasL- Cyclosporine A inhibits ANT and protects against cer-
induced apoptosis. These factors or settings include cyto- tain modes of apoptosis [8].
kines (TNF, IFNg, IL-1b, IL-1a), bacterial lipopolysac- The cells’ executioners are the caspases. Most caspases
charide (LPS), nephrotoxins, HIV infection, and depri- are constitutively expressed as inactive pro-enzymes
vation of survival factors [3, 15, 25, 30, 33]. Plasma from (pro-caspases) in the cytosol and, according to some
patients with thrombotic microangiopathy induces apo- reports, in the mitochondria. Caspases are sequentially
ptosis and Fas expression in renal microvascular endo- activated by proteolysis during apoptosis: initiator cas-
thelial cells [28]. CD27, a member of the TNFR family, pases activate downstream, effector caspases (Table 3)
also can induce apoptosis. Unlike TNFR1 and Fas, the [12]. Alternatively, proteases, such as granzyme B, that
are introduced into the cell by perforin-expressing cyto-cytoplasmic tail of CD27 lacks the DD. However, an-
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Fig. 4. Intracellular pathways for cell death
can be activated by death receptors or cell
stress and are antagonized by molecules such
as Bcl-2/BclxL, FLIP, IAP, and extracellular
survival factors.
toxic lymphocytes, activate caspases [8]. Pro-caspases Caspases also are classified according to their se-
possess considerably less activity than mature caspases. quence specificity [12]. Caspases with similar cleavage
As a result, recruitment and oligomerization of initiator specificity share inhibitors. Among the synthetic peptide
pro-caspases mediated by adaptor proteins (FLASH, inhibitors of caspases, YVAD inhibits caspase-1-like cas-
Apaf-1) constitute basic mechanisms of caspase activa- pases; DEVD, caspase-3-like caspases; IETD, caspase-
tion by proteolysis [8] (Fig. 4). Caspase-9, the initiator 8-like caspases; and zVAD inhibits all known caspases.
caspase of the mitochondrial pathway for apoptosis, is There are also viral inhibitors of caspases whose anti-
activated after binding to the cytosolic adaptor protein apoptotic properties might be used therapeutically. They
Apaf-1. Apaf-1 itself must be activated through a confor- include the cowpox virus CrmA serpin and the baculovi-
mational change that occurs in the presence of dATP rus p35 protein. CrmA inhibits mainly caspase-1 and
when cytochrome c is released from the mitochondria displays the second highest affinity for caspase-8; it is
[12]. Activated Apaf-1 molecules oligomerize and, to- unlikely that CrmA inhibits other caspases in vivo. In
gether with caspase-9, form a protein complex dubbed addition, CrmA also inhibits granzyme B and other ser-
the “apoptosome.” Caspases-8 and -10 are the initiator ine proteases. The p35 protein inhibits all caspases tested
caspases of lethal receptor-induced apoptosis; they be- so far. Endogenous caspase inhibitors in mammals include
come activated upon recruitment to the DISC. Caspase-8
the caspase-8 inhibitor FLIP, the caspase-3 and caspase-9
cleaves the pro-apoptotic member of the Bcl-2 family
inhibitors IAP (XIAP, cIAP1, cIAP2), and truncated,Bid, and Bid fragments migrate to the mitochondria,
dominant-negative isoforms of caspases [9, 12, 46].where they promote the mitochondrial pathway of apo-
Inhibition of caspases can prevent cell death. This isptosis in type II cells [8].
especially true in death induced by ligation of deathInitiator caspases (-8, -9, -10) activate effector caspases
receptors such as Fas, where the execution of the cell(-3, -6, -7). Effector caspases can, in turn, activate initia-
death depends on caspases. Thus inhibition of caspase-8tor caspases, thus propagating the apoptotic process [12].
by zVAD prevents lethal receptor-initiated downstreamMore than 40 substrates for caspases have been identified
intracellular events and cell death. However, in somewhose cleavage can be either an activating or inactivating
biologic systems of mitochondrial injury, caspase inhibi-event for the function of the protein. Most proteins
tors prevent features of apoptosis such as nuclearwhose cleavage leads to the characteristic apoptotic mor-
pyknosis and internucleosomal DNA degradation butphology are targeted by the effector caspases. Targets
do not increase overall cell survival. zVAD inhibits theinclude inactivation of protective proteins, such as BclxL
features of apoptosis induced by acetaminophen or hyp-and Bcl-2, that even can yield pro-apoptotic fragments,
oxia-reoxygenation in renal cells, but it does not preventdismantling of structural proteins, and activation of
DNAses [12]. eventual cell death [39] (abstract, Ortiz A, et al, J Am
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Soc Nephrol 9:444A, 1998). Experiments should be pro- those found in diabetes, up-regulated Bax mRNA and
down-regulated Bcl-2 and BclxL mRNAs in tubular epi-longed to exclude this possibility.
The complex phenotypes of the caspase knockout thelial cells [1]. Although neither survival cytokines nor
ECM modified these proteins in mesangial cells [16, 17],mice indicate that multiple mechanisms of caspase acti-
vation operate in parallel and that death signal transduc- a nitric oxide donor and oxygen radicals up-regulated
Bax expression in mesangial cells [40]. Bax up-regulationtion pathways are both cell-type and stimulus specific.
At least four different death pathways are provided by in this system might be related to p53 activation [40].
Down-regulation of BclxL expression indeed mightthe caspases-3 and -9 [12]. Not enough information is
available on which caspases are important in mediating have a role in tubular epithelial cell death, as preventing
the fall in BclxL levels in transfected cells affords protec-renal cell death. Studies employing inhibitors of caspases
suggest that different caspases are required for apopto- tion against apoptosis induced by nephrotoxins and le-
thal receptors [42]. This latter feature suggests that tu-sis induced by different stimuli. For example, DEVD-
CHO prevents cyclosporine A-, but not acetaminophen- bular epithelial cells are type II cells. Overexpression
of Bcl-2 also protected tubular epithelial cells from apop-induced, apoptosis in murine tubular epithelial cells [36].
Other proteolytic enzymes also become activated during tosis induced by cisplatin or hypoxia-reoxygenation
[37, 39]. Heat-shock proteins also protect from apoptosis.apoptosis, such as calpaine, a calcium-dependent cyste-
ine protease implicated in hypoxia-induced death of rat In mesangial cells, heat-shock protein 70 (Hsp70) over-
expression protected from IL-1b-mediated sensitizationproximal tubules [47].
Survival Bcl-2-like proteins (Table 4) protect against to apoptotic stimuli [49].
Several intracellular mediators have been implicatedcell death in which the mitochondrial pathways for apo-
ptosis are activated [10]. These proteins may fail to de- in death signaling. They include oxygen radicals, cera-
mide, and post-translational modification of proteinsfend against receptor-induced apoptosis, one exception
being type II cells, in which recruitment of pro-caspase-8 such as phosphorylation, nitrosylation, and proteolysis
[8–13]. Furthermore, in the course of apoptosis, the com-is inefficient and the lethal signal needs to be amplified
through the mitochondrial pathway. Apoptotic and anti- position of the intracellular milieu changes and these
changes facilitate caspase activation. Some apoptosisapoptotic members of the family can interact, and the
overall effect on cell survival might depend on the bal- pathways require new gene transcription (for example,
dexamethasone-induced death of lymphocytes) whileance between the activity of apoptotic (such as Bax and
BclxS) and anti-apoptotic (such as Bcl-2 and BclxL) pro- others do not (for example, Fas-induced apoptosis) [7].
In mesangial and tubular epithelial cells, protein synthe-teins [10]. Thus, it is difficult to draw conclusions from
descriptive papers in which the expression of just one sis inhibitors induce apoptosis and also sensitize to apo-
ptosis mediated by the death receptors TNFR and Fas;of these factors is reported. Scenarios in which anti-
apoptotic proteins bind to and inactivate apoptotic pro- these findings suggest that ongoing synthesis of protec-
tive proteins is required to prevent programmed cellteins and in which it is the apoptotic proteins that inacti-
vate anti-apoptotic members of the family have been death [16, 31]. Transcription factors participate in some
forms of apoptosis. However, their exact role varies withdescribed.
The mechanisms of the protection afforded by Bcl-2 cell type and the functional status of the cell. The c-myc
protein promotes apoptosis when the concentration offamily members is still being debated. Two theories have
emerged. In one, apoptosis is prevented by sequestering extracellular survival factors is low but favors cell divi-
sion in the presence of survival factors [11]. Interestingly,pro-caspases in the apoptosome. In this scenario, BclxL
binds to the complex formed by caspase-9, Apaf-1, and TNF induces both c-myc expression and apoptosis in
serum-deprived tubular epithelial cells [42]. P53 pro-cytochrome c and prevents caspase activation [10]. A
second scenario involves closing the VDAC and pre- motes apoptosis through pathways that can be both in-
dependent of, and dependent on, the transcriptionalventing the release of mitochondrial apoptogenic factors
such as cytochrome c and AIF into the cytoplasm [48]. down-regulation of Bcl-2 and up-regulation of Bax [11].
Nuclear factor-kB (NF-kB) is activated upon engage-This effect might be related to the ability of these pro-
teins to form transmembrane channels [10]. ment of some death receptors [9]. One function of NF-kB
is to prevent cell death, as is the case in mesangial cellsModulation of Bcl-2-like proteins by extracellular sur-
vival and lethal factors has been described in renal cells. exposed to TNF [50]. Activated protein-1 (AP-1) has
both apoptotic and anti-apoptotic effects [51]. IncreasedThe survival factors in serum up-regulated Bcl-2 and
BclxL expression and down-regulated Bax in murine expression of transcription factors has been noted in
the course of proliferative glomerular injury and tubulartubular epithelial cells, while lethal factors such as TNF
and acetaminophen down-regulated BclxL [42]. TNF damage, where their contribution to the regulation of
apoptotic cell death is difficult to evaluate.and LPS also down-regulated BclxL in glomerular endo-
thelial cells [28]. High glucose concentrations, similar to A number of molecular links between mitosis and cell
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death have been unraveled. Extracellular factors (EGF, bular hyperplasia in the recovery phase of acute renal
failure.IGF-I, HGF) have both survival and growth factor activ-
ity. Transcription factors such as c-myc, which are acti- Cell turnover in the healthy glomerulus is low. Apo-
ptotic cells represent about 0.01% of rat glomerular cellsvated in stressed cells, regulate cell division or cell death
[11]. Some cyclins and cylin-dependent kinases regulate in normal rat glomeruli and 0.03 cells/10 normal glomeru-
lar cross-sections in humans [57]. Resolution of the self-the cell cycle as well as apoptosis. Caspases degrade the
cdk2 inhibitors p21Cip1/Waf1 and p27Kip1, and the resultant limited mesangial proliferation characteristic of experi-
mental anti-Thy-1 nephritis depends on a high rate ofincrement in cdk2 activity has been implicated in apopto-
sis. Indeed, p27Kip1 2/2 mice develop more intense tubu- apoptosis of excessive mesangial cells, which exceeds the
rate of mitosis and peaks at 0.25% of glomerular cellslar proliferation and apoptosis following ureteral ob-
struction as well as more severe glomerulonephritis [52]. [57]. However, the rate of apoptosis returns to basal
levels before cell loss leads to glomerular hypocellularityOverexpression of Bcl-2 or BclxL protects from apopto-
sis and also decreases cell proliferation [10]. (Fig. 5A). By contrast, the rate of apoptosis was not
increased in nonproliferative, experimental membra-
Role of apoptosis in renal injury nous nephropathy [57].
A second peak of apoptosis occurs days to weeks (itCell death through apoptosis has been documented in
the course of renal injury both in animal models and initially peaks at day 8 in rat ischemic ARF) after the
original tubular insult that led to ARF, when the necroticclinical renal diseases, including glomerulonephritis,
acute and chronic renal failure, diabetic nephropathy, tubules have been completely reconstituted by a hyper-
plastic epithelium [45, 54]. In this setting, apoptosis canand polycystic kidney disease [6]. Apoptosis, both of
intrinsic renal cells and of infiltrating leukocytes, can restore cell number to pre-injury levels, but it also can
contribute to delayed recovery from ARF. This mightcontribute to the pathogenesis of renal disease. While
apoptosis participates in the loss of parenchymal cells at be especially true in the clinical setting. Contrary to the
experimental situation, in which a single insult causesseveral stages of renal injury, in fact apoptosis of intrinsic
renal cells can be deleterious or beneficial, and its role enough damage for the model to be reproducible, the
clinical setting is often characterized by repeated low-can change during the course of renal injury.
Apoptosis triggered by ischemia, exogenous toxins, or grade offenses. This low-grade renal damage leads to
tubular epithelial cell apoptosis, even in the absence ofendogenous mediators of damage can be the initial insult
that causes renal disease. Both agonistic anti-Fas anti- any clinical deterioration of renal function [58] and can
hamper recovery in previously damaged tubuli. Indeed,bodies and anti-Thy-1 antibodies induce mesangial cell
apoptosis in vitro and in vivo [31, 32, 53]. Agonistic anti- the definitive interpretation of the clinical significance
of this late apoptotic response awaits the results of thera-Fas antibodies cause complement-independent, acute,
mesangial cell apoptosis that is associated with transient peutic attempts to avoid the loss of tubular cells at this
stage. Insufficient apoptosis of fibroblasts can promoteproteinuria and hematuria [32]. By contrast, anti-Thy-1
antibodies cause complement-dependent mesangial cell accumulation of interstitial fibroblasts during renal scar-
ring; fibroblasts involved in wound repair typically areapoptosis that is followed by self-limited proliferative
glomerulonephritis [53]. Tubular cell death in the early eliminated by apoptosis [59].
When a high apoptotic rate, relative to the mitoticstages of acute renal failure can proceed through apopto-
sis or necrosis [45, 54–56]. The relative contribution of rate, of renal parenchymal cells persists beyond the re-
covery of normal tissue cellularity, it leads to the loss ofthe two mechanisms to the initial tubular cell loss is
uncertain and might depend on the severity of the insult. renal parenchymal cells that characterizes glomerular
sclerosis or tubular atrophy (Fig. 5B). Understanding theApoptosis also contributes to tissue remodeling and
recovery of normal tissue structure. A physiologic exam- molecular basis for the continued cell loss via apoptosis is
of utmost importance. The contribution of persistentple is renal development. Apoptosis decreases the mass
of unneeded metanephric mesenchyme following induc- apoptosis to mesangial and endothelial cell depletion has
been documented in experimental models of progres-tion by the ureteric bud, and altered apoptosis during
renal development can result in renal dysplasia or agene- sive glomerular scarring, such as crescentic antiglomer-
ular basement membrane, antibody-induced nephro-sis [18].
Evidence from experimental models of renal injury pathy [60, 61].
Consistent with the experimental data, an increasedsuggests that apoptosis coexists with renal cell prolifera-
tion. These cells might be more sensitive to absolute or rate of apoptosis was observed in human proliferative
nephritis such as IgA nephropathy and lupus nephritis,relative deficits in survival factors. In this case, apoptosis
represents a physiologic process to eliminate redundant especially in sclerosing lesions [62]. Follow-up studies
from human biopsies have not been done, so any conclu-cells and resolve an exaggerated proliferative response
to injury, such as proliferative glomerulonephritis or tu- sion regarding the consequences of apoptosis in the clini-
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Fig. 5. Schema of the relative timing and ex-
tent of apoptosis in relation to mitosis deter-
mines ultimate cell number. (A) Resolution of
injury. (B) Atrophy. Symbols are: dotted line,
apoptosis; dashed line, mitosis; solid line, live
cells. An excess apoptosis limited in time can
restore normal cell number (A), but persistent
apoptosis can result in tissue atrophy (B).
cal setting must be based on experimental data. Indeed, factors (possibly a consequence of a failure of the recog-
nition/engulfing mechanism) and (2) active release ofeither leukocytes or intrinsic renal cells might undergo
apoptosis. If leukocytes are being cleared, then apoptosis inflammatory cytokines [57].
Apoptosis of lymphocytes plays a fundamental role inmight contribute to healing. Moreover, mesangial cell
apoptosis possibly keeps in check an exaggerated prolif- the control of the immune response in the thymus and
erative response; but if the rate of mesangial cell apopto- the periphery [66]. While the details of this involvement
sis were too vigorous, it could lead to a reduction in the are beyond the scope of this review, it should be noted
number of glomerular cells [57, 60, 61]. An excess rate that altered expression of apoptosis-related proteins such
of apoptosis of tubular epithelial cells has been observed as Bcl-2, Fas, and FasL results in autoimmunity and
in experimental models of chronic tubular atrophy and renal damage [6, 66]. Apoptosis by itself can generate
human HIV nephropathy [4, 34, 63]. autoimmunity, as autoreactivity has been recognized
Many renal diseases are characterized by a mononu- against antigens present in apoptotic cells [66]. If apo-
clear cell infiltrate composed mainly of monocytes/mac- ptotic cells are not adequately cleared, their contents
rophages and T-cells. Inflammatory cells provide factors might be released and further stimulate this autoimmune
that cause parenchymal cell apoptosis. Monocytes/mac- response.
rophages release TNF, FasL, radical oxygen species, and
Apoptosis regulatory factors in specific renal diseasesnitric oxide. In contrast, the combination of perforin/
granzyme B and FasL accounts for most of the cytotoxic- The characterization of the factors that regulate apo-
ptosis during renal injury in vivo has lagged behind theity of T-lymphocytes [57]. Indeed, prevention of mono-
nuclear cell recruitment in MCP-1 2/2 mice decreased identification of apoptosis as a participant in renal cell
homeostasis. This lack of information, which is especiallytubular cell apoptosis associated with glomerular in-
flammation [64]. noteworthy in human biopsies, has hindered the develop-
ment of therapeutic strategies based on the modulationClearance of inflammatory cells by apoptosis contrib-
utes to resolution of renal inflammation [57], and failure of apoptotic cell death. Piecemeal data have emerged
regarding the expression of some of the earliest recog-of this clearance might contribute to the persistence of
the inflammatory process. Apoptosis of neutrophils is nized apoptosis regulatory proteins during glomerulone-
phritis, tubular injury, and polycystic kidney disease.prominent in nephrotoxic nephritis in the rat [57] and
likely is responsible for the high apoptosis rate observed In concordance with the observation of increased rates
of apoptosis in proliferative glomerulonephritis, changesin acute postinfectious glomerulonephritis in humans
[65]. Apoptotic leukocytes are engulfed by local cells, in the expression of apoptosis regulatory factors have
been observed in proliferative glomerular injury, but notlike mesangial cells [57].
Some researchers believe that apoptosis does not gen- in nonproliferative glomerulopathies. The interpretation
of these studies is frequently hampered by the difficultyerate inflammation. The relationship between apoptosis
and inflammation should be re-evaluated, however, as a of differentiating the cell type (intrinsic glomerular cell
versus leukocytes) that is expressing the apoptosis regu-mononuclear cell infiltrate frequently accompanies sites
of apoptosis [5]. Apoptosis itself might promote inflam- latory protein and, in human material, by the lack of
follow-up studies. Furthermore, few functional studiesmation through two mechanisms: (1) disintegration of
apoptotic cells with release of nonspecific inflammatory have addressed the role of specific apoptosis regulatory
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proteins in modifying the evolution of glomerular injury During acute transplant rejection, an increased tubular
apoptotic rate was associated with increased renal ex-in vivo.
Expression of lethal factors such as TNF and FasL pression of lethal factors (perforin/granzyme B, FasL),
increased tubular expression of Fas and p53, and a de-is increased in proliferative glomerular injury [25–27].
Increased expression of Fas, Bcl-2, and Bax has been creased Bcl-2/Bax ratio [72–74]. Information regarding
the expression of apoptosis regulatory proteins in humanobserved within the glomerulus in human proliferative
glomerulonephritis [67, 68]. However, Bcl-2 positivity native kidney acute renal failure is needed.
Less information is available regarding apoptosis regu-was limited to less than two cells/glomerulus and could
represent expression by infiltrating leukocytes [67]. Sig- latory factors in chronic progressive tubulointerstitial in-
jury. Increased tubular Fas expression has been notednificant Bcl-2 immunoactivity within the glomerular tuft
was not always apparent in a variety of proliferative and in mouse models of chronic renal atrophy [34]. Although
glomerular cell apoptosis is not a feature in diabeticnonproliferative glomerulonephritides, the expression be-
ing limited to epithelial cells in early crescents [69]. nephropathy, tubular cell apoptosis associated with de-
creased Bcl-2 and increased Bax mRNA expression wasThe expression of extracellular and intracellular apo-
ptosis regulatory factors changes over the time course observed [1]. This intracellular milieu also might predis-
pose to acute renal failure. Interestingly, apoptosis inof acute renal failure. A cytokine microenvironment per-
missive for cell death includes decreased renal levels of blastocysts exposed to high glucose levels depends on
increased Bax [75].survival factors (EGF, IGF-I) and increased cell mem-
brane survival factor receptors; these alterations indicate Altered apoptosis appears to have an important role
in polycystic kidney disease (PKD). Apoptosis is re-competition for survival factors [20]. Increased TNF and
FasL also have been observed in ARF and are matched quired for cystogenesis in an in vitro system in canine
MDCK cells, and prevention of apoptosis by overexpres-by high renal Fas expression in experimental models of
ARF [reviewed in 25, 26]. Furthermore, genetic defects sion of Bcl-2 inhibits cystogenesis [76]. Consistent with
this report, the lack of functional Bcl-2 results in exces-in Fas expression protect against tubular injury during
ARF induced by ischemia-reperfusion or ureteral ob- sive renal apoptosis and hypoplastic kidneys with a re-
duced number of nephrons and PKD [reviewed in 77].struction [25, 26]. Siva mRNA and CD27 receptor were
expressed in the early phase following renal ischemia Polycystic kidney disease also develops in other mouse
models with genetic defects in apoptosis-related genes.as well as in a second phase in epithelial cells of regen-
erating tubules, in association with the two peaks of Dysregulation of c-myc in the kidneys of SBM mice
results in PKD and increased proliferation and apoptosisapoptosis [45].
Changes in tubular Bcl-2-like proteins also have been in the absence of changes in Bcl-2 or Bax expression.
Also, AP-2b 2/2 mice die postnatally because of PKDnoted. In murine obstructive-toxic ARF induced by an
overdose of folic acid, tubular expression of Bax and that is associated with massive tubular apoptosis.
The proteins encoded by the PKD1 and PKD2 genesBclxL is increased and Bcl-2 decreases [42]. These
changes are transient (24 to 72 hours) and reminiscent might participate in interactions with extracellular li-
gands [77]. I am not aware whether the intriguing possi-of those observed during a well-characterized model of
epithelial apoptosis: involution of the mammary gland bility that they influence cell survival or death has been
formally addressed. Human autosomal dominant PKDafter weaning. Immunohistochemistry showed that renal
tubular cells with up-regulated BclxL expression coexist (ADPKD) is characterized by increased c-myc expres-
sion in cysts as well as increased rates of proliferationwith cells that had lost the basal BclxL expression [42].
These findings are consistent with data from central ner- and apoptosis despite increased Bcl-2. Apoptosis also
has been implicated in the loss of normal renal paren-vous system ischemia, in which BclxL was increased in
surviving neurons and decreased in damaged neurons chyma in ADPKD.
[70]. The competence for survival factors might explain
Future perspectiveswhy tubular cells with access to survival factors up-regu-
late BclxL, and those deprived of them down-regulate Although incomplete, the available in vitro and in vivo
data suggest that apoptosis and its regulatory moleculesBclxL [42]. Bax was localized to apoptotic cells in the
tubular wall and lumen in this model by immunohisto- contribute to a variety of renal diseases. Understanding
the role and regulation of apoptosis in renal disease haschemistry. Tubular Bcl-2 is increased in the rat ischemia-
reperfusion model of ARF [71]. However, in this model the potential to provide the basis for the design of new
therapeutic strategies as well as to improve our under-the Bcl-2 increment was restricted to the first few days
after injury, while Bax was increased on days 1 and standing of the mode of action of current therapies.
Newer therapies might include drugs that interfere with7, resulting in a decreased Bcl-2/Bax ratio at the time
and location of apoptotic clearing of hyperplastic epithel- apoptosis, cytokines and their antagonists, antisense
strategies, and local delivery of apoptosis regulatoryium [71].
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genes. Future research should focus on the definition of approach includes improving disposal of the apoptotic
cells, which would prevent their lysis and limit inflamma-the cellular and molecular targets as well as the optimal
time frame for therapeutic intervention in each renal tion and the release of autoantigens [57]. Corticosteroids
foster the nonphlogistic disposal of apoptotic cells [82].pathology. Special consideration should be given to opti-
mizing modes of local delivery of apoptosis modulatory The identification of cell-specific promoters will facilitate
targeting of lethal genes, such as Fas or FADD, to pre-therapies so as to target only specific cell populations
during a limited time period. Otherwise, we risk interfer- vent accumulation of excess fibroblasts.
ing with physiologic apoptosis taking place during renal
healing or in other organs and thus inducing untoward
QUESTIONS AND ANSWERS
effects. For instance, the systemic antagonism of Fas
Dr. John T. Harrington (Dean, Tufts Universitycan result in autoimmunity in mice [reviewed in 25]. A
School of Medicine, Boston, Massachusetts, USA): Al-theoretical risk of promoting neoplasia can be predicted
berto, thank you for a wonderful review of an exceed-if there are no temporal limits to Bcl-2-like survival pro-
ingly complex issue. Is apoptosis controlled only withintein overexpression. It should be remembered that Bcl-2
each cell, or at a higher organizational level? Of thewas originally characterized as an oncogene [10]. Con-
former, which will we be fighting when we attack apopto-versely, attempts at increasing the clearance of unwanted
sis at the clinical level?mesangial or tubular cells could be complicated by renal
Dr. Ortiz: Apoptosis is controlled by intracellularatrophy.
regulators within each cell. However, apoptosis is a re-Among the cellular targets, we might be interested in
sponse to the cell microenvironment, and the cell micro-prolonging parenchymal cell survival in chronic renal
environment can be controlled at a higher organizationalatrophy and acute renal failure. Survival cytokines and
level. For example, hormone-deprivation-induced apo-lethal cytokine antagonists already have been used in
ptosis or plasma glucose concentration are controlled at aexperimental renal disease. Both EGF and IGF-I im-
higher organizational level. In theory, we could interfereprove the evolution of experimental ARF and decrease
with apoptosis therapeutically at both levels. But bytubular cell apoptosis [20, 55]. A more selective delivery
directing therapy at the intracellular mediators of apo-of the survival factor could be envisioned. Gene-transfer-
ptosis, we should be able to limit the untoward effectsinduced overexpression of the membrane-bound form
derived from unintentionally modulating apoptosis inof HB-EGF in tubular epithelial cells has a local anti-
non-target cells.apoptotic action [19]. Antagonism of TNF improves the
Dr. Harrington: How much of the difference in sizeevolution of experimental models of acute renal failure
between normal and end-stage renal disease kidneys isand glomerulonephritis [reviewed in 26]. Although TNF
due to apoptosis? Let’s say one had a patient with chronicinduces apoptosis, the contribution of direct inhibition
IgA nephropathy.of apoptosis to the therapeutic effect of its antagonists
Dr. Ortiz: That question goes to the heart of theis difficult to discern. Specific targeting of Bcl-2–like sur-
possible therapeutic interest of interfering with apopto-vival proteins also might be of value in the therapy of
sis. Most of the loss of renal mass during the progressionrenal diseases. Studies in tubular epithelial cells have
of chronic renal injury is due to renal cell loss. In fact,demonstrated that feasibility and effectiveness of gene
the histologic appearance of end-stage renal disease, in-transfer strategies for promoting the expression of Bcl-2
dependent of the etiology of renal injury, is characterizedor BclxL and preventing tubular epithelial apoptosis in
by glomerular sclerosis with loss of intrinsic glomerularvitro [37, 39, 42]. Even though in vivo studies in the
cells, tubular atrophy, and increased extracellular matrix.kidney are lacking, the local overexpression of Bcl-2 in
Despite the increased proportion of extracellular matrix,transgenic mice decreased cerebral infarction size by
these kidneys are small; their reduced size emphasizes50% [78]. Local delivery of dominant-negative FADD
the importance of intrinsic renal cell loss. While an acuteconstructs protects targeted cells from death-receptor-
insult can result in both apoptotic and necrotic cell deathmediated apoptosis [9]. Inhibition of caspases also pro-
[83], chronic loss of renal cells proceeds through apopto-tects from cell death mediated by death receptors in
sis [83]. Moreover, a correlation exists between tubularvivo. In laboratory animals, the systemic administration
cell apoptosis and tubular atrophy in experimental pro-of zVAD prevented Fas-induced liver injury [79] and
gressive renal failure [63]. Thus, I believe that apoptosisdecreased the size of myocardial infarction by 20% when
accounts for most of the cell loss in chronic renal injury.assessed early [80]. By contrast, DNAse inhibition did
Dr. Emil Andreev (Assistant Professor of Clinicalnot prevent cell death [81].
Nephrology, Medical University-Sofia, Sofia, Bulgaria):Conversely, leukocytes and fibroblasts can be targeted
Do the terms “apoptosis” and “programmed cell death”with apoptotic maneuvers. Two of the most widely used
refer to the same phenomenon?immunosuppressive drugs, corticosteroids and cyclo-
sporine A, promote lymphocyte apoptosis [57]. Another Dr. Ortiz: The term apoptosis used to refer to a spe-
Nephrology Forum: Apoptotic regulatory proteins 479
cific cell morphology, but researchers later learned that of the patient contributed to the tubular epithelial cell
the apoptotic morphology corresponded to an active apoptosis, either directly or indirectly.
form of cell death that required the participation of intra- Dr. Behrooz Broulmand (Professor of Medicine,
cellular cell-death machinery. The term programmed cell Irna University of Medical Sciences, Tehran, Iran): Let
death, which originated in the embryologic literature, me ask a slightly different question. What is the role
refers to the fact that certain cells die during a specific of the different clinical processes in this patient in the
stage of development. Programmed cell death usually induction of tubular epithelial cell apoptosis?
has the morphology of apoptosis, and both terms can be Dr. Ortiz: As I said earlier, this patient had diabetes
used interchangeably. mellitus, HIV infection, HCV (hepatitis C virus) infec-
Dr. Zofia Niemir (Assistant Professor, University of tion, and glomerulonephritis. All of these entities might
Poznan, Poznan, Poland): TNF-a and TGF-b1 are ex- have contributed to tubular epithelial cell apoptosis. Hy-
pressed in human glomerulonephritis [84]. Could these perglycemia decreases tubular epithelial cell prolifera-
factors regulate apoptosis in the human kidney? tion and induces an imbalance in gene expression, char-
Dr. Ortiz: TNF-a and TGF-b1 have been implicated acterized by low BclxL/Bax and Bcl-2/Bax ratios, which
in the pathogenesis of a variety of renal diseases [26, 85]. favors the occurrence of cell death [1]. HIV infection
Both of these factors can induce apoptosis in non-renal promotes Fas expression and apoptosis in cultured tubu-
cells and theoretically could influence renal cell apopto- lar epithelial cells [3]. The role, if any, of HCV infection
sis. In fact, TGF-b1 and TNF-a induce apoptosis in cul- is undefined. Recent evidence suggests that HCV RNA is
tured tubular epithelial cells [42, 86], and TNF-a pro- present in tubular epithelial cells [87]. However, whether
motes glomerular endothelial cell apoptosis [28]. By this virus influences the cell’s susceptibility to apoptosis
contrast, mesangial cells, when grown in an optimal cul- remains unknown. Contradictory evidence regarding the
ture medium, are quite resistant to TNF-a-induced apo- influence of HCV infection in apoptosis has been re-
ptosis because of activation of NF-kB by TNF-a [50]. In ported in liver cells. Although HCV infection increases
addition, TGF-b1 was reported not to affect mesangial hepatocyte Fas expression [88], both apoptotic and anti-
cell survival [16]. But TNF-a and TGF-b1 might regulate apoptotic actions of HCV core protein have been re-
apoptosis through additional mechanisms. In this regard, ported in hepatocyte cell lines [89]. Glomerular inflam-
TNF-a induces Fas expression and sensitizes murine mation also could have contributed to tubular epithelial
mesangial cells and renal fibroblasts to Fas-mediated cell cell apoptosis. Apoptotic cytokines such as TNF and
death [22, 31], whereas TGF-b1 modulates the composi- FasL are expressed in inflamed glomeruli, and at least
tion of the extracellular matrix [85], which in turn influ- TNF leaks into the urinary space [26, 27].
ences cell survival [17].
Dr. Ratan Jha (Consultant Nephrologist, Medwin
Dr. Fernando Valderra´bano (Professor of Medicine,
Hospital, Hyderabad, Andhra Pradesh, India): What is
University Complutense, Madrid, Spain): My question
the relevance of the concept of apoptosis to the practicerefers to the case presented. We all know that tubuloin-
of clinical nephrology?terstitial damage is a poor prognostic factor in glomerular
Dr. Ortiz: Apoptotic cell death is a tightly regulateddiseases, but what is the meaning of the presence of
process that offers the potential for therapeutic interven-tubular apoptotic cells in this patient with type I diabetes,
tion. Understanding the role and regulation of apoptosisHIV infection, and mesangial proliferative glomerulone-
in renal injury can provide new therapeutic approachesphritis?
aimed at preventing intrinsic renal cell loss or modulatingDr. Ortiz: At present, it is difficult to determine the
inflammation and fibrosis. Changes in renal cell num-role of apoptosis in an individual patient. Indeed, as I
ber—either increased cell number, as in the course ofpointed out, we do not have enough information about
proliferative glomerulonephritis, or decreased cell num-the role of apoptosis in a variety of renal diseases. Such
ber, as in renal atrophy—are frequently observed in theinformation will be complete only when we are able
course of renal injury.to interfere with apoptosis therapeutically. The clinical
Dr. Thomas H. Ittel (Chief, Department of Medicine,course of the patient under discussion suggests that tubu-
Professor of Medicine, University of Greifswald, Stral-lar cell loss through apoptosis was causally related to
sund, Germany): Fas expression is up-regulated in HIV-renal dysfunction, and that tubular cell apoptosis was
infected tubular epithelial cells. What is the contributionnot a “compensatory” response to an excessive cell num-
of overexpression of macrophage/monocyte proteins,ber. The intense degree of tubular cell apoptosis ob-
such as TNF-a, IL-1, and IL-6, to tubular epithelial cellserved in this patient could represent an acute tubular
apoptosis in HIV infection?injury in association with chronic glomerular disease.
Dr. Ortiz: Both TNF-a and IL-1a induce apoptosisHowever, no evidence of hemodynamic instability or
in cultured tubular epithelial cells [34, 42], but the TNF-use of potentially nephrotoxic agents could be found. I
believe that one or several of the medical conditions a-induced apoptosis is a delayed phenomenon, observed
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after 48 to 72 hours and associated with decreased BclxL endothelial cells, and fibroblasts [96–98]. Both AT-1 and
AT-2 receptors have been implicated in angiotensin II-expression [42].
Dr. Ittel: How does HIV infection affect survival induced apoptosis [96–98]. The information on the effect
of ACE inhibitors and AT-1 blockers on the occurrenceproteins and antagonists of apoptosis such as Bcl-2 and
BclxL? of apoptosis in the kidney is scarce. Our group recently
observed that therapy with either quinapril or the AT-1Dr. Ortiz: HIV infection can promote apoptosis. Sev-
eral mechanisms have been implicated in HIV-induced receptor antagonist losartan reduced the rate of tubular
epithelial cell apoptosis in spontaneously hypertensiveapoptosis, most of them in immune system cells. Viral
proteins, such as viral protein R, can induce apoptosis rats with renal mass reduction (Soto K, unpublished ob-
servations). Losartan also decreased apoptosis of tubularvia a direct effect on the mitochondrial permeability
transition pore complex [91]. Several death ligand-recep- and interstitial cells that was associated with cyclosporine
A nephrotoxicity in rats [99]. However, it is uncleartor complexes, such as FasL-Fas, TNF-TNFRII, and
TRAIL also have been implicated in apoptosis occurring whether the therapeutic effect of ACE inhibitors and
AT-1 blockers on renal apoptosis is the consequencein leukocytes from HIV-infected individuals [90, 92]. In
addition, down-regulation of Bcl-2 has been reported in of their hemodynamic effects, or whether their benefit
depends on the inhibition of a direct apoptotic effect oflymphocyte subsets infected by HIV or exposed to HIV
proteins [93] and Bclx induction was delayed and re- angiotensin II on renal cells. In another study, mice null
mutant for the AT-2 gene had a greater accumulationsponses decreased in stimulated HIV-infected peripheral
blood mononuclear cells [94]. However, up-regulation of interstitial fibroblasts than did controls, and this find-
ing was associated with a lower interstitial cell apoptoticof Bcl-2 by HIV protein products also has been reported
[95]. It is conceivable that the effect of HIV infection rate [100].
Dr. Istvan Musi (Assistant Professor, Semmelweison apoptosis gene expression varies with the stage of
infection and cell type. Medical University, Budapest, Hungary): What is the role
of the different mitogen-activated protein kinases (MAPDr. Ahmad Mooraki (Associate Professor, Iran Uni-
versity of Medical Sciences, Tehran, Iran): What specific kinases) in the regulation of apoptosis?
Dr. Ortiz: MAP kinases include extracellular signal-genes contribute to apoptosis that leads to renal atrophy
in glomerulonephritis? Can we study those genes to de- regulated protein kinases (ERKs), stress-activated pro-
tein kinase/c-jun N-terminal kinases (JNKs), and p38termine the contribution of apoptosis or necrosis to renal
atrophy? kinases [101]. MAP kinases, which play a role in the
transmission of signals from the cell microenvironmentDr. Ortiz: The subject of which genes are relevant to
renal cell death is under intense investigation, but it to the transcriptional machinery, have been implicated
in apoptotic pathways. JNKs and p38 kinases have beenis unlikely that studying gene expression will help us
determine the contribution of apoptosis or necrosis to implicated in the induction of apoptosis and ERKs in
protection from apoptosis. However, different roles ofrenal atrophy. Given the existence of multiple apoptotic
regulatory genes and the fact that apoptosis is the result these kinases might be envisioned in different cell types
and in response to different stimuli. In rat mesangialof the balance between the cell microenvironment and
the intracellular expression of several apoptotic and anti- cells, a correlation was found between sustained JNK
activation and apoptosis induced by TNF-a [102]. Byapoptotic factors, analysis of the expression of a particu-
lar gene will not predict whether apoptosis will occur. contrast, ERKs have been suggested as having both apo-
ptotic and anti-apoptotic effects on cultured mesangialHowever, investigational therapy aimed at a particular
apoptotic regulatory gene that can prevent or induce cells [103].
Dr. Musi: What are the molecular details of the regu-apoptosis might provide us with information regarding
the contribution of apoptosis to renal atrophy. lation of apoptosis by extracellular matrix?
Dr. Ortiz: The extracellular matrix can modulate cellDr. Jesus Egido (Professor of Medicine, Autonoma
University and Fundacio´n Jime´nez Dı´az, Madrid, Spain): survival through activation of integrin receptors. Cell
death induced by loss of integrin-mediated contacts withAngiotensin II has been implicated in apoptosis of cardi-
omyocytes during chronic heart failure, and this process the extracellular matrix is termed anoikis [104]. Frisch
et al have proposed that JNK is a mediator of anoikiscan be reversed by angiotensin converting enzyme
(ACE) inhibitors and angiotensin II type 1 (AT-1) recep- [104]. Anoikis requires caspase activation and is inhib-
ited by Bcl-2 [104]. In addition, anoikis in tubular epithe-tor blockers. Would you comment on the potential role
of angiotensin II in the apoptosis of chronic renal failure, lial cells is associated with caspase-8 and Bid activation
and inhibited by so-called silencer-of-death domainsas well as on the AT receptors implicated in this phenom-
enon? (SODD) and dominant-negative FAS-associated death
domain protein (FADD); both findings suggest theDr. Ortiz: Angiotensin II promotes apoptosis in a
variety of cultured cell types, including cardiomyocytes, involvement of death receptors in the process [105].
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Dr. Hemani J. Mehta (Consultant Nephrologist, Lila- phase (2 to 8 days) characterized by cell death effected
by both apoptosis and necrosis, that is associated withvati Hospital, Mumbai, Maharashtra, India): What is the
role of apoptosis of intrinsic renal cells and fibroblasts increased tubular epithelial cell mitosis [83]. In a subse-
quent chronic phase (10 to 28 days), when the mass ofin chronic transplant nephropathy?
Dr. Ortiz: Apoptosis contributes to cell number regu- the ischemic kidney underwent significant reduction, cell
death was caused by apoptosis alone, and the level oflation of the kidney at several stages following en-
graftment. Ischemia with subsequent reperfusion in- tubular epithelial cell mitosis returned to nearly normal
[83]. But we have limited information in humans aboutduces tubular cell apoptosis, and the number of apoptotic
renal tubular epithelial cells in biopsy specimens from the existence of apoptosis in renal conditions character-
ized by chronic ischemia.donor kidneys before engraftment is predictive of the
early postoperative course in patients undergoing renal Dr. Dumler: I have another question. Do any data
suggest that apoptosis per se increases production oftransplantation [106]. An increased rate of tubular cell
apoptosis also contributes to cell loss in the course of normal (that is, type IV collagen) or abnormal (that is,
type I and type III collagen) extracellular matrix?acute and chronic graft rejection and cyclosporine ne-
phropathy [107]. Apoptosis of infiltrating leukocytes also Dr. Ortiz: Apoptosis in tissue sections frequently is
associated with fibrosis. In the kidney, chronic tubularhas been reported in the course of renal allograft rejec-
tion. However, information on fibroblast apoptosis is atrophy is associated with renal fibrosis and thickened
tubular basement membranes. However, the relationshipscarce. It is conceivable that an insufficient rate of fibro-
blast apoptosis contributes to fibroblast accumulation between extracellular matrix and apoptosis is complex.
The extracellular matrix influences renal cell survival:and renal fibrosis [22].
Dr. Harrington: Caloric restriction prolongs survival physiologic components of normal mesangial extracellu-
lar matrix, such as collagen IV and laminin, promoteand modulates gene expression. Is there any information
on the effect of caloric restriction on apoptotic gene mesangial cell survival; collagen I does not [17]. By con-
trast, whether apoptosis per se increases the productionexpression?
Dr. Ortiz: Caloric restriction is the only intervention of extracellular matrix is not known. It is unlikely that
dying cells can secrete extracellular matrix, but theythat appears to slow the intrinsic rate of aging. One of
the possible mechanisms of action of caloric restriction might promote inflammation or cytokine secretion by
adjacent cells [111, 112] that in turn promotes extracellu-is modulation of gene expression. Aging is associated
with changes in the expression of apoptotic regulatory lar matrix deposition. Moreover, several apoptotic stim-
uli, such as TGF-b1 or hyperglycemia, also increase ex-genes, such as down-regulation of anti-apoptotic HSP70,
and up-regulation of anti-apoptotic HSP27 [108]. Caloric tracellular matrix production. To my knowledge, the
question whether the apoptotic cells per se contributerestriction prevented the rise in HSP27 but had no effect
on the down-regulation of HSP70 associated with aging to matrix deposition has not been addressed.
Dr. Egido: Your group has shown that tubular epithe-[108]. These changes induced by caloric restriction might
increase the sensitivity of aged cells to apoptosis. Indeed, lial cells as well as T cells express FasL [27]. Could you
speculate on the biologic and pathophysiologic role ofcaloric restriction increased the rate of hepatocyte apo-
ptosis and retarded the development of spontaneous mu- FasL in those renal cells?
Dr. Ortiz: FasL originally was described as a T-cell-rine hepatoma [109]. The effect of dietary restriction on
other apoptosis-related genes, and in particular in renal specific cytokine [reviewed in 25]. More recently, a vari-
ety of cell types, including leukocytes, epithelial cells,cells, has not been addressed, however. In this regard,
the progressive decline in renal function associated with endothelial cells, and fibroblasts, have been shown to
express FasL. In these cell types, FasL could be an auto-aging has been related to an increased rate of apoptosis
of tubular and interstitial cells [110]. crine regulator of apoptosis. However, much attention
has been drawn to a role for FasL in limiting immuneDr. Francis Dumler (Chief of Nephrology, William
Beaumont Hospital, Royal Oak, Michigan, USA): An or inflammatory responses. Thus, FasL expression by
retinal pigment epithelial cells has been implicated in eyeexcessive rate of glomerular cell apoptosis theoretically
could lead to decreased glomerular size, similar to that immune tolerance [113]. In addition, FasL expression
by the endothelium has been proposed as a means ofobserved in chronic ischemia. Is there any evidence of
an increased apoptotic rate in clinical conditions such as preventing leukocyte extravasation by inducing apopto-
sis of adherent leukocytes [114]. As I mentioned earlier,chronic renal ischemia, hypertension, or renovascular
disease, in which the intraglomerular pressure is low? FasL also induces apoptosis of renal interstitial fibro-
blasts [22]. On this basis, we have speculated that FasLDr. Ortiz: Chronic ischemia is a cause of apoptotic
cell death leading to atrophy in various organs, including expression by tubular epithelial cells has a role in limiting
immune or inflammatory response within the kidney [27].the kidney in experimental models [83]. Following the
induction of renal artery stenosis in rats, there is an acute Dr. Benmail Hedi (Professor of Medicine, Faculte´
Nephrology Forum: Apoptotic regulatory proteins482
Medecine de Tunis, Tunis, Tunisia): What is the pre- Dr. Ortiz: B-cell chronic lymphocytic leukemia
dictive value of the number of apoptotic cells in glomeru- (B-CLL) represents a neoplastic disorder caused not by
lar nephropathies, such as acute and chronic glomerulo- increased cell proliferation but primarily by defective
nephritis? Is there a relationship between the number apoptosis, which leads to the accumulation of neoplastic
of apoptotic cells and the timing of renal biopsy? CD51 B lymphocytes [117]. Bcl-2 is overexpressed in
Dr. Ortiz: Little information is available on the exis- more than 80% of B-CLLs. However, the mechanisms
tence and meaning of apoptosis in human renal biopsy responsible for this high expression are poorly under-
tissue. In animal models, the number of apoptotic cells stood, as they only rarely involve rearrangements of the
varies according to the natural history of glomerulone- Bcl-2 gene as a result of chromosomal translocations,
phritis, and one should expect that the timing of renal unlike the follicular B-cell non-Hodgkin’s lymphomas
biopsy influences the number of apoptotic cells. In an [117]. Other regulators of apoptosis also might contrib-
acute, self-limited rat model of proliferative glomerulo- ute to increased cell survival, as higher levels of the anti-
nephritis induced by the injection of anti-Thy-1 antibod- apoptotic protein Mcl-1 were strongly correlated with
ies, the onset and peak of apoptosis occurs after the peak failure to achieve complete remission after single-agent
of cell proliferation. Savill and colleagues showed that therapy [117].
apoptosis eliminated the excess glomerular cells and re-
stored normal glomerular cellularity [57]. By contrast, ACKNOWLEDGMENTS
in progressive experimental glomerular injury, the rate
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